Improving outcomes for patients with chronic hepatitis B.

about

Management of hepatitis B in liver transplant recipients.Nuclear factor kappa B and hepatitis viruses.Current antiviral therapies for chronic hepatitis B.

P2860

Q36980721-2015F907-A60C-4C93-8E29-D29468285434 Q37082762-711ACC6C-9446-46F5-921A-63FA4E9C9AAB Q40096242-4D5279DF-ED3F-4B8D-8A80-7E00178125B7

P2860

Improving outcomes for patients with chronic hepatitis B.

Item

http://www.wikidata.org/entity/Q45949258

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Improving outcomes for patients with chronic hepatitis B.

@en

Improving outcomes for patients with chronic hepatitis B.

@nl

type

Item

label

Improving outcomes for patients with chronic hepatitis B.

@en

Improving outcomes for patients with chronic hepatitis B.

@nl

prefLabel

Improving outcomes for patients with chronic hepatitis B.

@en

Improving outcomes for patients with chronic hepatitis B.

@nl

P1476

Improving outcomes for patients with chronic hepatitis B

@en

P2093

Robert G Gish

http://www.w3.org/2001/XMLSchema#string

P2860

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine

Immunology of hepatitis B virus and hepatitis C virus infection

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil

Genomic analysis of the host response to hepatitis B virus infection.

Vaccination against hepatitis B: current challenges for Asian countries and future directions.

P304

S67-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1872-034X.2007.00108.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert Gish

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17627639

http://www.w3.org/2001/XMLSchema#string

Improving outcomes for patients with chronic hepatitis B.

about

P2860

P2860

Improving outcomes for patients with chronic hepatitis B.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698